Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health

The current distribution scope would continue, while fiscal 2027 and long-term adjusted earnings growth guidance remain unchanged.

Rhea-AI Summary

Cardinal Health (CAH) has entered into a binding letter of intent to extend its existing distribution agreement with CVS Health through June 30, 2032.

The extension would continue the current scope of distribution services. In connection with the renewal, Cardinal Health reaffirmed fiscal year 2027 non-GAAP earnings per share guidance of $12.40 to $12.60, representing 13% to 15% growth, and long-term non-GAAP earnings per share growth guidance of 12% to 14%. Further updates may be provided during its November 5, 2026 first-quarter earnings call.

3 points · 0 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 0 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Moderate point. Forward-looking: it has not happened yet and may not happen.Binding letter of intent would extend CVS Health distribution services through June 30, 2032, maintaining current scope.
• Minor point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 non-GAAP EPS guidance reaffirmed: $12.40 to $12.60, representing 13% to 15% growth.
• Minor point. Forward-looking: it has not happened yet and may not happen.Long-term non-GAAP EPS growth guidance reaffirmed at 12% to 14%.

Negative

• None.

Key Figures

Distribution agreement extension: Through June 30, 2032 FY2027 non-GAAP EPS: $12.40 to $12.60 FY2027 non-GAAP EPS growth: 13% to 15% +1 more

Distribution agreement extension

Through June 30, 2032

Binding letter of intent; continuation of current distribution-services scope

FY2027 non-GAAP EPS

$12.40 to $12.60

Reaffirmed guidance

FY2027 non-GAAP EPS growth

13% to 15%

Reaffirmed guidance

Long-term non-GAAP EPS growth

12% to 14%

Reaffirmed guidance

Historical Context

1 past event · Latest: Aug 11

1 event

1. Aug 11

   earnings guidance

   24h Move

   +1.1%

   Established FY2027 non-GAAP EPS guidance of $12.40–$12.60 and 13%–15% growth.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

letter of intent, non-gaap eps

2 terms

letter of intent financial

"entered into a binding Letter of Intent to extend its existing distribution agreement"

A letter of intent is a document that shows an agreement in principle between parties to work towards a future deal or transaction. It outlines their intentions and key terms, acting like a roadmap before a formal contract is signed. For investors, it signals serious interest and helps clarify expectations early in the process.

non-gaap eps financial

"reaffirmed its fiscal year 2027 non-GAAP EPS guidance"

Non-GAAP EPS is a measure of a company's profit per share that excludes certain expenses or income items that are included in standard accounting reports. It is used by investors to get a clearer picture of the company's core performance, much like removing one-time costs from a personal budget to see regular spending habits. This adjusted figure helps investors compare companies more consistently and understand their ongoing profitability.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services.

"We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers," stated Jason Hollar, CEO of Cardinal Health.

In connection with the renewal, Cardinal Health has reaffirmed its fiscal year 2027 non-GAAP EPS guidance of 13% to 15% growth¹ ($12.40 to $12.60) and its long-term non-GAAP EPS growth rate guidance of 12% to 14%. Further updates may be provided during the company's upcoming first quarter earnings call on November 5, 2026.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom. 

Contacts 
Media: Erich Timmerman, erich.timmerman@cardinalhealth.com and 614.757.8231
Investors: David Frost, david.frost@cardinalhealth.com and 614.757.7852

¹ Growth rates for fiscal year 2027 guidance based upon adjusted fiscal year 2026 results which exclude the fiscal year 2026 benefit from IEEPA tariff refund.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-enters-into-binding-letter-of-intent-to-extend-pharmaceutical-distribution-agreements-with-cvs-health-302895833.html

SOURCE Cardinal Health

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How long would Cardinal Health's CVS Health distribution agreement be extended?

The binding letter of intent would extend the existing distribution agreement through June 30, 2032, continuing Cardinal Health's current scope of distribution services.

What earnings guidance did Cardinal Health reaffirm with the CVS Health renewal?

Cardinal Health reaffirmed fiscal year 2027 non-GAAP earnings per share guidance of $12.40 to $12.60, representing 13% to 15% growth. It also reaffirmed long-term non-GAAP earnings per share growth guidance of 12% to 14%.